King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar dothedow (89.38) Submitted: 5/3/2008 12:41:16 AM : Outperform Start Price: $9.62 KG Score: +50.90

valuepick

Featured Broker Partners


Advertisement